Finapres Medical Systems is a pioneering company in the healthcare industry, providing cutting-edge technology for continuous non-invasive blood pressure measurement and autonomic testing. Established in 2002 and based in The Netherlands, Finapres has been at the forefront of developing and distributing medical devices and software for totally non-invasive hemodynamic monitoring, backed by over 30 years of research and user-experiences in this field. The company's flagship product, Finapres® NOVA, is a revolutionary hemodynamic monitoring system that offers accurate non-invasive continuous blood pressure monitoring through a finger cuff. It is based on the most accurate and robust continuous non-invasive measurement of blood pressure, combined with model-based computation of cardiac output and stroke volume using the Modelflow® technology. Finapres' innovative solutions, such as Finapres® NOVA Basic, Finapres® NOVA ECG + Resp, and Finapres® NOVA SpO2, along with their advanced software applications, have garnered worldwide acceptance and are currently utilized by prestigious research institutes and renowned hospitals including NASA, Harvard, Johns Hopkins, and Mayo Clinic. With a strong focus on enhancing diagnostic capabilities in areas such as syncope and POTS, Finapres is positioned as a leader in its niche. As the company continues to drive innovation and expand its product offerings, it presents an exciting opportunity for potential investors seeking to support advancements in non-invasive hemodynamic monitoring technology. For more information, visit www.finapres.com or reach out to [email protected].
There is no investment information
No recent news or press coverage available for Finapres Medical Systems.